A Large Scale Study of Angiotensin II Inhibition Therapy in an Elderly Population: the Chance Study

References

• AndrawesWFBussyCBelminJPrevention of cardiovascular events in elderly peopleDrugs Aging2005228597616245959
   PubMed Web of Science ®Google Scholar
• AsmarRPorcellatiCDusingRSwitch from ABCD pre-treatment to A-II-A treatment: a multinational open, centrally randomized, prospective parallel group comparisonDrugs Exp Clin Res2004301536115553661
   PubMedGoogle Scholar
• AsmarRVolSPannierBHigh blood pressure and associated cardiovascular risk factors in FranceJ Hypertens20011917273211593091
   PubMed Web of Science ®Google Scholar
• BerlowitzDRAshASHickeyECInadequate management of blood pressure in a hypertensive populationN Engl J Med19983391957639869666
   PubMed Web of Science ®Google Scholar
• ChaudhrySIKrumholzHMFoodyJMSystolic hypertension in older personJAMA200429210748015339901
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRThe Seventh Report of the Joint National Committee on Preventions, Detection, Evaluation, and Treatment of High Blood PressureJAMA200328925607212748199
   PubMed Web of Science ®Google Scholar
• CushmanWCFordCECutlerJASuccess and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)J Clin Hypertens20024393404
   PubMedGoogle Scholar
• DahlofBLindholmLHHanssonLMorbidity and mortality in the Swedish Trial and Old Patients with Hypertension (STOP Hypertension)Lancet1991265128151682683
   PubMedGoogle Scholar
• ElmfeldtDGeorgeMHubnerRCandesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effectJ Hum Hypertens199711S49539331007
   PubMed Web of Science ®Google Scholar
• [ESH] Guidelines CommitteeEuropean Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertensionJ Hypertens20032110115312777938
   PubMed Web of Science ®Google Scholar
• [HAS] Haute Authorité de SantéPrise en charge des patients adultes atteints d'hypertension artérielle essentielle. Actualisation des recommendations2005 Private communication
   Google Scholar
• KjeldsenSEDahlofBDevereuxRBLowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan intervention for endpointAm J Hypertens20001389990610950398
   PubMed Web of Science ®Google Scholar
• MeredithPAchieving quality 24-h blood pressure control with candesartan cilexetilBlood Press Suppl2000123611059632
   PubMedGoogle Scholar
• MulrowCDCornellJAHerreraCRHypertension in the elderly. Implications and generalizability of randomized trialsJAMA1994272193287990246
   PubMed Web of Science ®Google Scholar
• NeldamSForsenBMulticentre Study Group. Antihypertensive treatment in elderly patients aged 75 years or over: a 24-week study of the tolerability of candesartan cilexetil in relation to hydrochlorothiazideDrugs Aging2001182253211302289
   PubMed Web of Science ®Google Scholar
• O'BrienEAsmarRBeilinLEuropean Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurementJ Hypertens2003218214812714851
   PubMed Web of Science ®Google Scholar
• OparilSLevineJHZuschkeCAEffects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study InvestigatorsAm J Cardiol1999842899310496437
   PubMed Web of Science ®Google Scholar
• ReifMWhiteWBFaganTCEffects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study InvestigatorsAm J Cardiol19988296159794352
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research GroupPrevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP)JAMA19912653255642046107
   PubMed Web of Science ®Google Scholar
• SkoogILithellHHanssonLEffect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on Cognition and Prognosis in the Elderly (SCOPE)Am J Hypertens2005181052916109319
   PubMed Web of Science ®Google Scholar
• StaessenJAFagardRThijsLRandomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial InvestigatorsLancet1997350757649297994
   PubMed Web of Science ®Google Scholar
• ThijsLHondEDNawrotTPrevalence, pathophysiology and treatment of isolated systolic hypertension in the elderlyExpert Rev Cardiovasc Ther20042761915350177
   PubMedGoogle Scholar
• ThomasGNChanPTomlinsonBThe role of angiotensin II type 1 receptor antagonists in elderly patients with hypertensionDrugs Aging2006231315516536636
   PubMed Web of Science ®Google Scholar
• TrenkwalderPEfficacy and tolerability of candesartan cilexetil in special patient groupsBlood Press Suppl20001273011059633
   PubMedGoogle Scholar
• TrenkwalderPElmfeldtDHofmanAThe Study on COgnition and Prognosis in the Elderly (SCOPE) - major CV events and stroke in subgroups of patientsBlood Press20051431715823945
   PubMed Web of Science ®Google Scholar
• TurnbullFBlood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trialsLancet200336215273514615107
   PubMed Web of Science ®Google Scholar
• VaccarinoVBergerAKAbramsonJPulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly programAm J Cardiol200188980611703993
   PubMed Web of Science ®Google Scholar
• VasanRSBeiserASeshadriSResidual life time risk for developing hypertension in middle-aged women and men: the Framingham Heart StudyJAMA200228710031011866648
   PubMed Web of Science ®Google Scholar